Suppr超能文献

枸橼酸盐样本管中分析前钙水平极低,可能导致凝血因子V促凝活性的血浆水平和纤维蛋白原浓度被低估,同时凝血酶原时间、活化部分凝血活酶时间和凝血酶时间延长。

Underestimation of plasma level of factor V coagulant activity and fibrinogen concentration together with prolonged prothrombin time, activated partial thromboplastin time and thrombin time can result from pre-analytical very low calcium level in citrated sample tube.

作者信息

d'Audigier C, Delassasseigne C, Robert A, Eschwège V

机构信息

Laboratoire d'Hématologie, EFS Bourgogne - Franche-Comté, Besançon, France.

Hôpital Saint-Antoine, Service d'Hématologie Biologique, AP-HP, Paris, France.

出版信息

Int J Lab Hematol. 2016 Feb;38(1):50-3. doi: 10.1111/ijlh.12434. Epub 2015 Sep 25.

Abstract

INTRODUCTION

Pre-analytical phase is a critical step in the haemostasis laboratory cycle. Numerous variations affect tests results, and it is crucial to detect them in order to reject improper specimens before reporting test results. Comparing to prior results or requesting, a repeat sample can help in pre-analytical irregularity assessment.

METHODS

Each time a sample addressed to our laboratory displayed aberrant results or discordant with a prior report, another specimen was asked and both were analysed through calcium (Ca) level, prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), fibrinogen concentration, factor II, factor VII+X and factor V coagulant activity measurements. Among these, all the primary citrated samples from inpatients without anticoagulant treatment, displaying very low calcium level ('Ca 0' samples), were selected for this 2 years study.

RESULTS

A total of 17 samples could be identified. Ca level in their paired repeat samples was always >1.00 mmol/L. Coagulation testing for 'Ca 0' samples showed a significant prolongation of PT, APTT, TT and a significant decrease for fibrinogen concentration and factor V coagulant activity.

CONCLUSION

We identified factor V coagulant activity, as the parameter with the most important variation in case of very low calcium level in presumed citrated sample tubes probably contaminated with EDTA.

摘要

引言

分析前阶段是止血实验室流程中的关键步骤。众多变量会影响检测结果,在报告检测结果前检测出这些变量以拒收不合格样本至关重要。与先前结果或要求相比,重复采样有助于分析前异常情况评估。

方法

每当送至我们实验室的样本显示出异常结果或与先前报告不一致时,就会要求采集另一份样本,并通过钙(Ca)水平、凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、纤维蛋白原浓度、因子II、因子VII+X和因子V凝血活性测量对两份样本进行分析。其中,所有来自未接受抗凝治疗的住院患者且显示钙水平极低(“Ca 0”样本)的枸橼酸盐抗凝原始样本被选入这项为期2年的研究。

结果

总共识别出17个样本。其配对重复样本中的钙水平始终>1.00 mmol/L。对“Ca 0”样本进行的凝血检测显示PT、APTT、TT显著延长,纤维蛋白原浓度和因子V凝血活性显著降低。

结论

我们确定因子V凝血活性是疑似被乙二胺四乙酸(EDTA)污染的枸橼酸盐样本管中钙水平极低情况下变化最为显著的参数。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验